Cargando…
Synthesis and Antiangiogenic Activity of Novel Gambogic Acid Derivatives
Gambogic acid (GA) is in a phase II clinical trial as an antitumor and antiangiogenesis agent. In this study, 36 GA derivatives were synthesized and screened in a zebrafish model to evaluate their antiangiogenic activity and toxicity. Derivatives 4, 32, 35,36 effectively suppressed the formation of...
Autores principales: | Chen, Tao, Zhang, Rong-Hong, He, Shi-Chao, Xu, Qin-Yuan, Ma, Liang, Wang, Guang-Cheng, Qiu, Neng, Peng, Fei, Chen, Jin-Ying, Qiu, Jing-Xiang, Peng, Ai-Hua, Chen, Li-Juan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6268492/ https://www.ncbi.nlm.nih.gov/pubmed/22634837 http://dx.doi.org/10.3390/molecules17066249 |
Ejemplares similares
-
Improving aqueous solubility and antitumor effects by nanosized gambogic acid-mPEG(2000) micelles
por: Cai, Lulu, et al.
Publicado: (2013) -
Investigations into the antibacterial effects and potential mechanism of gambogic acid and neogambogic acid
por: Li, Mingzhu, et al.
Publicado: (2022) -
Structural Optimization and Improving Antitumor Potential of Moreollic Acid from Gamboge
por: Cheng, Li-Zhi, et al.
Publicado: (2022) -
Research Progress in the Field of Gambogic Acid and Its Derivatives as Antineoplastic Drugs
por: Li, Meng, et al.
Publicado: (2022) -
Gambogic Acid as a Candidate for Cancer Therapy: A Review
por: Liu, Yuling, et al.
Publicado: (2020)